lornoxicam and Systemic-Inflammatory-Response-Syndrome

lornoxicam has been researched along with Systemic-Inflammatory-Response-Syndrome* in 1 studies

Trials

1 trial(s) available for lornoxicam and Systemic-Inflammatory-Response-Syndrome

ArticleYear
[The systemic inflammatory response syndrome correction in acute destructive pancreatitis].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2011, Issue:7

    Acute pancreatitis is a disease of variable severity. In which some patients experience mild, self-limited attacks while others manifest a severe, highly morbid, and frequently lethal attack. The exact mechanisms by which diverse etiological factors induce an attack are still unclear. Recent studies have established the role played by inflammatory mediators in the pathogenesis of acute pancreatitis. In our research we have estimated influence of not steroid anti-inflammatory preparation on synthesis pro-and anti-inflammatory Cytokines at healthy donors and at patients with Acute pancreatitis.

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cell Culture Techniques; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Injections, Intravenous; Leukocytes, Mononuclear; Ligands; Pancreatitis, Acute Necrotizing; Piroxicam; Systemic Inflammatory Response Syndrome; Toll-Like Receptor 1; Toll-Like Receptor 2; Toll-Like Receptor 4; Young Adult

2011